EVRON GEL— 510(k) K961222

Substantially Equivalent

Pharmaceutical Innovations, Inc.

FDA 510(k) clearance K961222 for EVRON GEL, Substantially Equivalent on 1996-06-26. Applicant: Pharmaceutical Innovations, Inc..

Clearance details

Applicant: Pharmaceutical Innovations, Inc.
Product code: Code KMJ
Advisory panel: General Hospital
Date received: 1996-03-28
Decision date: 1996-06-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.